Leveraging the EU AI Act to your advantage

Using the EU AI Act to your advantage
from
  • Guidelines for the risk assessment of AI use cases
  • Recommendations for the successful realization and implementation of the AI Act, as well as for the strategic orientation in the company
  • Exemplary use cases with concrete risk analysis

Subscribe now to the Merantix Momentum Newsletter.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

More articles

The latest industry news, interviews, technologies and resources.

How do you make 30 years of data accessible?

In conversation with Jonas Münch, who developed a RAG chatbot at Bayer that combines 30 years of internal data and clinical results in one place.

Building Better Medicines: Exploring AI-Driven Compound Optimization

An expert interview on research into AI-driven drug optimization.

How do you make 30 years of data accessible?

In conversation with Jonas Münch, who developed a RAG chatbot at Bayer that combines 30 years of internal data and clinical results in one place.

AI-Driven Compound Optimization in the Large Molecule Space

An expert interview on AI-Driven Compound Optimization in the Large Molecule Space.

Putting AI predictions into practice

An expert interview on the topic of AI-supported predictions.

Leveraging the EU AI Act to your advantage

  • Guidelines for the risk assessment of AI use cases
  • Recommendations for the successful realization and implementation of the AI Act, as well as for the strategic orientation in the company
  • Exemplary use cases with concrete risk analysis
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.

Discover more whitepapers

The AI Canvas: Our tool for project evaluation

Discover the AI Canvas!

Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

Towards Tabular Foundation Models

About the status quo, challenges and opportunities

Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

The AI Canvas: Our tool for project evaluation

Discover the AI Canvas!

Towards Tabular Foundation Models

About the status quo, challenges and opportunities
We would like to get to know you!

Start your AI journey with us now

Subscribe now to the Merantix Momentum Newsletter.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.